People: ACE Ltd (ACE.N)

ACE.N on New York Stock Exchange

108.66USD
22 May 2015
Change (% chg)

$-0.24 (-0.22%)
Prev Close
$108.90
Open
$108.78
Day's High
$108.97
Day's Low
$108.45
Volume
344,886
Avg. Vol
394,686
52-wk High
$117.88
52-wk Low
$99.46

Search Stocks

Atieh, Michael 

Mr. Michael G. Atieh is an Independent Director of ACE Limited. since September 1991. Mr. Atieh is Executive Vice President and Chief Financial and Business Officer of Ophthotech Corporation (a biopharmaceutical company). From February 2009 until its acquisition in February 2012, Mr. Atieh was Executive Chairman of Eyetech Inc., a private specialty pharmaceutical company. He served as Executive Vice President and Chief Financial Officer of OSI Pharmaceuticals from June 2005 until December 2008. He also served as a member of the Board of Directors and Chairman of the Audit Committee for OSI Pharmaceuticals from June 2003 to May 2005. Previously, Mr. Atieh served at Dendrite International, Inc. as Group President from January 2002 to February 2004 and as Senior Vice President and Chief Financial Officer from October 2000 to December 2001. He also served as Vice President of U.S. Human Health, a division of Merck & Co., Inc., from January 1999 to September 2000, as Senior Vice President—Merck-Medco Managed Care, L.L.C., an indirect wholly-owned subsidiary of Merck, from April 1994 to December 1998, as Vice President—Public Affairs of Merck from January 1994 to April 1994 and as Treasurer of Merck from April 1990 to December 1993.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Evan Greenberg

19,678,200

John Keogh

6,896,630

John Lupica

5,348,130

Philip Bancroft

4,318,280

Timothy Boroughs

--

Sean Ringsted

4,049,550
As Of  30 Dec 2014
Search Stocks